Harrison SA - Search Results

1

Cenicriviroc Treatment for Adults With Nonalcoholic Steatohepatitis and Fibrosis: Final Analysis of the Phase 2b CENTAUR Study.

Ratziu V, Sanyal A, Harrison SA, Wong VW, Francque S, Goodman Z, Aithal GP, Kowdley KV, Seyedkazemi S, Fischer L, Loomba R, Abdelmalek MF, Tacke F. Ratziu V, et al. Among authors: harrison sa. Hepatology. 2020 Sep;72(3):892-905. doi: 10.1002/hep.31108. Epub 2020 Jul 21. Hepatology. 2020. PMID: 31943293 Clinical Trial.

2

Diabetic hepatosclerosis: diabetic microangiopathy of the liver.

Harrison SA, Brunt EM, Goodman ZD, Di Bisceglie AM. Harrison SA, et al. Arch Pathol Lab Med. 2006 Jan;130(1):27-32. doi: 10.5858/2006-130-27-DHDMOT. Arch Pathol Lab Med. 2006. PMID: 16390234 Free article.

3

Impact of obesity on treatment of chronic hepatitis C.

Charlton MR, Pockros PJ, Harrison SA. Charlton MR, et al. Among authors: harrison sa. Hepatology. 2006 Jun;43(6):1177-86. doi: 10.1002/hep.21239. Hepatology. 2006. PMID: 16729327 Review.

4

Orlistat for overweight subjects with nonalcoholic steatohepatitis: A randomized, prospective trial.

Harrison SA, Fecht W, Brunt EM, Neuschwander-Tetri BA. Harrison SA, et al. Hepatology. 2009 Jan;49(1):80-6. doi: 10.1002/hep.22575. Hepatology. 2009. PMID: 19053049 Clinical Trial.

5

Importance of changes in adipose tissue insulin resistance to histological response during thiazolidinedione treatment of patients with nonalcoholic steatohepatitis.

Gastaldelli A, Harrison SA, Belfort-Aguilar R, Hardies LJ, Balas B, Schenker S, Cusi K. Gastaldelli A, et al. Among authors: harrison sa. Hepatology. 2009 Oct;50(4):1087-93. doi: 10.1002/hep.23116. Hepatology. 2009. PMID: 19670459 Clinical Trial.

6

Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection.

Starley BQ, Calcagno CJ, Harrison SA. Starley BQ, et al. Among authors: harrison sa. Hepatology. 2010 May;51(5):1820-32. doi: 10.1002/hep.23594. Hepatology. 2010. PMID: 20432259 Review.

7

Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases.

Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS; American Association for the Study of Liver Diseases. Bacon BR, et al. Hepatology. 2011 Jul;54(1):328-43. doi: 10.1002/hep.24330. Hepatology. 2011. PMID: 21452290 Free PMC article. No abstract available.

8

Insulin sensitizers in nonalcoholic steatohepatitis.

Harrison SA, Schenker S, Cusi K. Harrison SA, et al. Hepatology. 2011 Apr;53(4):1404-5; author reply 1405. doi: 10.1002/hep.24179. Hepatology. 2011. PMID: 21480350 No abstract available.

9

Rosiglitazone versus rosiglitazone and metformin versus rosiglitazone and losartan in the treatment of nonalcoholic steatohepatitis in humans: a 12-month randomized, prospective, open- label trial.

Torres DM, Jones FJ, Shaw JC, Williams CD, Ward JA, Harrison SA. Torres DM, et al. Among authors: harrison sa. Hepatology. 2011 Nov;54(5):1631-9. doi: 10.1002/hep.24558. Hepatology. 2011. PMID: 21748770 Clinical Trial.

10

Association of coffee and caffeine consumption with fatty liver disease, nonalcoholic steatohepatitis, and degree of hepatic fibrosis.

Molloy JW, Calcagno CJ, Williams CD, Jones FJ, Torres DM, Harrison SA. Molloy JW, et al. Among authors: harrison sa. Hepatology. 2012 Feb;55(2):429-36. doi: 10.1002/hep.24731. Epub 2011 Dec 22. Hepatology. 2012. PMID: 21987293

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

385 results

Search Page

Filters